Right ventricular adaptation to pressure overload

Current Opinion in Critical Care

Volumn 16, Issue 3, 2010, Pages 237-243

  Simon, Marc A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Heart failure; Pulmonary heart disease; Pulmonary hypertension; Remodeling

Indexed keywords

ALTEPLASE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; HEPARIN; PLANT EXTRACT; PROSTACYCLIN; PROSTANOID; PROTANDIM; SILDENAFIL; UNCLASSIFIED DRUG;

ADAPTATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OVERLOAD; HUMAN; LUNG EMBOLISM; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; TISSUE DOPPLER IMAGING;

ACUTE DISEASE; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; ECHOCARDIOGRAPHY; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 77952382720     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283382e58     Document Type: Review

References (51)

1. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009; 120:992-1007.
2. McDonald MA, Ross HJ. Trying to succeed when the right ventricle fails. Curr Opin Cardiol 2009; 24:239-245.
3. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echo- cardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr 2009; 22:776-792.
4. Haddad F, Couture P, TousignantC, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg 2009; 108:407-421.
5. Haddad F, Couture P, TousignantC, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg 2009; 108:422-433.
6. Scherptong RWC, Vliegen HW, Winter MM, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation 2009; 119:1467-1472.
7. Pedonto A, Amar D. Right heart function in thoracic surgery: role of echocardiography. Curr Opin Anaesthesiol 2009; 22:44-49.
8. Bogaard HJ, Abe K, Vonk-Noordegraaf A, Voelkel NF.The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135:794-804.
9. Kline JA, Steuerwald MT, Marchick MR, et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism. Chest 2009; 136:1202-1210.
10. Zagorski J, Gellar MA, Obraztsova M, et al. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol 2007; 179:7820-7826.
11. Begieneman MP, van de Goot FR, van der Bilt IA, et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart 2008; 94:450-456.
12. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-349.
13. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126:78S-92S.
14. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106:1477-1482.
15. Badesch DB, Abman SH, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131:1917-1928.
16. Barst RJ, Galie N, Naeije R, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J 2006; 28:1195-1203.
17. McLaughlin VV. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan. Eur J Clin Invest 2006; 36 (Suppl 3):10-15.
18. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114:1883-1891.
19. Zaobornyj T, Valdez LB, Iglesias DE, et al. Mitochondrial nitric oxide meta- bolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments. Am J Physiol Heart Circ Physiol 2009; 296: H1741-H1747.
20. Nagendran J, Archer SL, Soliman D, et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007; 116: 238-248.
21. Nagendran J, Gurtu V, Fu DZ, et al. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg 2008; 136:168-178.
22. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005; 45:1849-1855.
23. Nagendran J, Michelakis ED. Mitochondrial NOS is upregulated in the hypoxic heart: implications for the function of the hypertrophied right ventricle. Am J Physiol Heart Circ Physiol 2009; 296:1723-1726.
24. Bogaard HJ, Natarajan R, Henderson SC, et al. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009; 120:1951-1960.
25. KuehneT, Yilmaz S, SteendijkP, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004; 110:2010-2016.
26. Hunter KS, Lee P, Lanning CJ, et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. Am Heart J 2008; 155:166-174.
27. Ghofrani HA, Barst RJ, Benza RL, et al. Future perspectives for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S108-S117.
28. Badesch DB, Champion HC, Gomez Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55-S66.
29. Benza R, Biederman R, Murali S, Gupta H. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol 2008; 52:1683-1692.
30. McLure LER, Peacock AJ. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J 2009; 33:1454-1466.
31. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28:1250-1257.
32. Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J Am Coll Cardiol Img 2009; 2:286-295.
33. Reiter G, Reiter U, Kovacs G, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 2008; 1:23-30.
34. Simon MA, Deible C, Mathier MA, et al. Phenotyping the right ventricle in patients with pulmonary hypertension. Clin Transl Sci 2009; 2:294-299.
35. Rajagopalan N, Simon MA, Mathier MA, Lopez-Candales A. Identifying right ventricular dysfunction with tissue Doppler imaging in pulmonary hypertension. Int J Cardiol 2008; 128:359-363.
36. Simon MA, Rajagopalan N, Mathier MA, et al. Tissue Doppler imaging distinguishes hemodynamic right ventricular decompensation in pulmonary hypertension. Congest Heart Fail 2009; 15:271-276.
37. Sade LE, Gülmez Ö, Özyer U, et al. Tissue Doppler study of the right ventricle with a multisegmental approach: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2009; 22:361-368.
38. Matias C, Perez de Isla L, Vasconcelos M, et al. Speckle-tracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressure. J Cardiovasc Med 2009; 10:129-134.
39. Jategaonkar SR, Scholtz W, Butz T, et al. Two-dimensional strain and strain rate imaging of the right ventricle in adult patients before and after percutaneous closure of atrial septal defects. Eur J Echocardiogr 2009; 10:499-502.
40. Lopez-Candales A, Dohi K, Rajagopalan N, et al. Right ventricular dyssynchrony in patients with pulmonary hypertension is associated with disease severity and functional class. Cardiovasc Ultrasound 2005; 3:23.
41. Hardziyenka M, Campian ME, Bouma BJ, et al. Right-to-left ventricular diastolic delay in chronic thromboembolic pulmonary hypertension is associated with activation delay and action potential prolongation in right ventricle. Circ Arrhythm Electrophysiol 2009; 2:555-561.
42. Hinderliter AL, Willis PW, Barst RJ, et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997; 95:1479-1486.
43. Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, et al. Effects of epoprostenol on right ventricular hypertrophy and dilation in pulmonary hypertension. Chest 2004; 125:572-579.
44. Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987; 76:135-141.
45. Chin KM, Kingman M, de Lemos JA, et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol 2008; 101:1669-1672.
46. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53:1573-1619.
47. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-2537.
48. Garjani A, Afrooziyan A, Nazemiyeh H, et al. Protective effects of hydroalco- holic extract from rhizomes of Cynodon dactylon (L.) Pers. on compensated right heart failure in rats. BMC Complement Altern Med 2009; 9:28. doi:10.1186/1472-6882-9-28.
49. Hoashi T, Matsumiya F, Miyagawa S, et al. Skeletal myoblast sheet trans- plantation improves the diastolic function of a pressure-overloaded right heart. J Thorac Cardiovasc Surg 2009; 138:460-467.
50. Lumens J, Arts T, Broers B, et al. Right ventricular free wall pacing improves cardiac pump function in severe pulmonary arterial hypertension: a computer simulation analysis. Am J Physiol Heart Circ Physiol 2009; 297:H2196-H2205.
51. Handoko ML, Lamberts RR, Redout EM, et al. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol 2009; 297:H1752-H1759.